Cynata Therapeutics Ltd has released a press release.
Cynata Partner apceth GmbH & Co Completes Cymerus Evaluation
Filed with ASX ·
6ix hasn’t read this filing yet.
Cynata Therapeutics Limited on 6ix
Story so far
Earlier from Cynata Therapeutics
- CYP Advances Development of Cymerus for Treatment of Asthma
- Final GvHD Preclinical Report Confirms Treatment Benefit
- Positive Preliminary Data from Preclinical HeartAttack Study
- Appendix 4C - quarterly
- Cynata Successfully Completes Capital Raising
Later from Cynata Therapeutics
- CYP in Collaboration on Acute Respiratory Distress Syndrome
- CYP Files for New Patent for Oncology Applications
- Cynata Advances to Pre-IND Meeting with US FDA
- March 2017 Quarterly Report
- Treatment Commences in Cynatas World First Clinical Trial
Follow Cynata Therapeutics into a list and get an email when it puts out news.
Follow Cynata Therapeutics